Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns

References

• Armatas GS, Kanatzidis MG. 2006. Mesostuctured germanium oxide with cubic pore symmetry. Nature. 441:1122–1125.
   PubMed Web of Science ®Google Scholar
• Alyautdin RN, Reichel A, Lobenberg R, Ramge P, Kreuter J, Begley DJ. 2001. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J Drug Target. 9: 209–221.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. 2012. Doxil® - The first FDA-approved nano-drug: lessons learned. J Control Release. 160:117–134.
   PubMed Web of Science ®Google Scholar
• Block JE, Thorn MR. 2000. Clinical indications of calcium-phosphate biomaterials and related composites for orthopedic procedures. Calcif Tissue Int. 66:234–238.
   PubMed Web of Science ®Google Scholar
• Boris MH, Reichert JC, Schantz JT, Gbureck U, Rackwitz L, Nöth U, et al. 2013. How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Del Rev. 65:581–603.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WCW. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cell. Nano Lett. 6:662–668.
   PubMed Web of Science ®Google Scholar
• Clift MJ, Rutishauser BR, Brown DM. 2008. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol. 232:418–427.
   PubMed Web of Science ®Google Scholar
• LaVan DA, McGuire T, Langer R. 2003. Small scale systems for in vivo drug delivery. Nat Biotechnol. 21:1184–1191.
   PubMed Web of Science ®Google Scholar
• Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. 2002. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298:1759–1762.
   PubMed Web of Science ®Google Scholar
• Duncan R. 2003. The dawning era of polymer therapeutics. Nat Rev Drug Disc. 2:347–360.
   PubMed Web of Science ®Google Scholar
• Duncan R. 2006. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 6:688–701.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. 2009. Impact of nanotechnology on drug delivery. ACS Nano. 3:16–20.
   PubMed Web of Science ®Google Scholar
• Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171.
   PubMed Web of Science ®Google Scholar
• Fubini B. 1997. Surface reactivity in the pathogenic response to particulates. Environ health perspect 105:1013–1020.
   PubMed Web of Science ®Google Scholar
• Gao H, Shi W, Freund LB. 2005. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA. 102:9469–9474.
   PubMed Web of Science ®Google Scholar
• Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schultz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytotic mechanisms in lungs and in cultured cells. Environ Health Perspect. 113:1555–1560.
   PubMed Web of Science ®Google Scholar
• Gash AE, Tilltson TM, Satcher JH, Hrubesh LW, Simpson RL. 2001. New sol-gel synthetic route to transition and main group metal oxide aerogels using inorganic salt precursors. J Non-cryst Solids. 285:22–28.
   Web of Science ®Google Scholar
• Gladstone HB, Mc Dermott MW, Cooke DD. 1995. Implants for cranioplasty, Otolaryngol. Clin North Am. 28:381–400.
   Web of Science ®Google Scholar
• Harper S, Usenko C, Hutchison JE, Maddux BLS, Tanguay RL. 2008. In vivo biodistribution and toxicity depends on nanomaterial composition, size, surface functionalization and route of exposure. J Exp Nanosci. 3:195–206.
   Web of Science ®Google Scholar
• Hrkach J, Von Hoff D, Ali MM, Andrianova E, Auer J, Campbell T, et al. 2012. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 4:128–139.
   Web of Science ®Google Scholar
• Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology. 260:142–149.
   PubMed Web of Science ®Google Scholar
• JinJin S, Wang Z, Wang L, Wang H, Li L, Yu X, Zhang J, Ma R, Zhang Z. 2013. Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer. Int J Nanomedicine. 8:1551–1562.
   PubMed Web of Science ®Google Scholar
• Kohane DS. 2007. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng. 96:203–209.
   PubMed Web of Science ®Google Scholar
• Kevadiya BD, Bajaj HC. 2013. The layered silicate montmorillonite as a drug delivery. Key Eng Mat. 571:111–132.
   Google Scholar
• Lade M, Mays H, Schmidt J, Willumeit R, Schomacker R. 2000. On the nanoparticle synthesis in microemulsions: detailed characterization of an applied reaction mixture. Colloids Surf A Phys Chem. 163:3–15.
   Web of Science ®Google Scholar
• Li X, Kanjwal MA, Lin L, Charonakis IS. 2013. Electrospun polyvinyl-alcohol nanofibres as oral fast-dissolving delivery system of caffeine and riboflavin. Key Eng Mat. 103:182–188.
   Google Scholar
• Linkov I, Satterstrom FK, Corey LM. 2008. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine Nanotech Bio Med. 4:167–171.
   PubMed Web of Science ®Google Scholar
• Liu J. 2014. Hyperbranched polyether hybrid nanospheres with CdSe quantum dots incorporated for selective detection of nitric oxide. Mater Lett. 123:104–106.
   Web of Science ®Google Scholar
• Lo S, Kumar A, Hsieh JT, Sun X. 2013. Dendrimers nanoscaffold for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm. 10:793–812.
   PubMedGoogle Scholar
• Marchant GE. 2009. Small is beautiful: what can nanotechnology do for personalized medicine? Curr Pharmacogenomics Person Med. 7:231–237.
   Google Scholar
• Medina SH, El-Sayed Mohd EH. 2009. Dendrimers as carriers for delivery agents. Chem Rev. 109:3141–3157.
   PubMed Web of Science ®Google Scholar
• Miller K, Erez R, Segal E, Shabat D, Satchi-Fainaro R. 2009. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer–alendronate–taxane conjugate. Angew Chem Int Ed. 48:6387–6392.
   Google Scholar
• Muhlfeld C, Gehr P, Rothen-Rutishauser B. 2008. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly. 138:387–391.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery a review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and Nanostructured lipid carriers (NLC) in cosmetic and dermatological preparation. Adv Drug Deliv Rev. 54:5131–5155.
   Google Scholar
• Muro S, Schuchman EH, Muzykantov VR. 2006. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Mol Ther. 13: 135–141.
   PubMed Web of Science ®Google Scholar
• Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano- bio interface. Nat. Mater. 8:543–557.
   PubMed Web of Science ®Google Scholar
• Oberdorster G. 2010. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Int Med. 267:89–105.
   PubMed Web of Science ®Google Scholar
• Paveer U, Ingrid T, Lust A. 2014. Soluplus Graft copolymer: potential novel carrier polymer in electrospinning of nanofibrous drug delivery systems for wound therapy. Biomed Res Int. 2014:789765. Article ID 789765
   PubMedGoogle Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2:751–760.
   PubMed Web of Science ®Google Scholar
• Porter AE, Muller K, Skepper J, Midgley P, Welland M. 2006. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater. 2:409–419.
   PubMed Web of Science ®Google Scholar
• Porter AE, Gass M, Muller K, Skepper JN, Midgley PA, Welland M. 2007. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2:713–717.
   PubMed Web of Science ®Google Scholar
• Quan CY, Chang C, Wei H, Chen CS, Xu XD, Cheng SX, et al. 2009. Dual targeting of a thermosensitive nanogel conjugated with transferrin and RGD-containing peptide for effective cell uptake and drug release. Nanotechnology. 20:335101.
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. 2006. Nanocarriers: Promising vehicle for bioactive drugs. Biol Pharm Bull. 29:1790–1798.
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. 2008. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm. 34: 181–188.
   PubMed Web of Science ®Google Scholar
• Riman RE, Suchanek WL, Lencka MM. 2002. Hydrothermal crystallization of ceramics. Ann Chim Sci Mat. 27:15–36.
   Web of Science ®Google Scholar
• Roy R, Kumar S, Tripathi A, Das M, Dwivedi PD. 2014. Interactive threats of nanoparticles to the biological system. Immunol Lett. 158:79–87.
   PubMed Web of Science ®Google Scholar
• Sakamoto JH, van de Ven AL, Godin B, Blanco E, Serda RE, Grattoni A, et al. 2010. Enabling individualized therapy through nanotechnology. Pharmacol Res. 62:57–89.
   PubMed Web of Science ®Google Scholar
• Sanvicens N, Marco MP. 2008. Multifunctional nanoparticles– properties and prospects for their use in human medicine. Trends Biotechnol. 26:425–433.
   PubMed Web of Science ®Google Scholar
• Schins RP, Duffin R, Hohr D, Knaapen AM, Shi T, Weishaupt C, et al. 2002. Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells. Chem Res Toxicol. 15:1166–1173.
   PubMed Web of Science ®Google Scholar
• Shi J, Yu X, Wang L, Liu Y, Gao J, Zhang J, et al. 2013. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. Biomaterials. 34: 9666–9677.
   PubMed Web of Science ®Google Scholar
• Shibahara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. 2004. On the cyto-toxicity caused by quantum dots. Microbiol Immunol. 48:669–675.
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kagan VE, Fadeel B. 2010. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev Pharmacol Toxicol. 50:63–88.
   PubMed Web of Science ®Google Scholar
• Singh D, Dubey P, Pradhan M, Rawat M. 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Deliv. 10:241–259.
   PubMed Web of Science ®Google Scholar
• Singer JW, Shaffer S, Baker B, Bernareggi A, Stromatt S, Nienstedt D, Besman M. 2005. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anticancer Drugs. 16:2223–228.
   Google Scholar
• Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Hohr D, et al. 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxic Appl Pharmacol. 222:141–151.
   PubMed Web of Science ®Google Scholar
• Stefani D, Wardman D, Lambert T. 2005. The implosion of the Calgary General Hospital: ambient air quality issues. J Air Waste Manag Assoc. 55:52–59.
   PubMedGoogle Scholar
• Suh WH, Suslick SK, Stucky Galen D, Suh YH. 2009. Nanotechnology, nanotoxicology, and neuroscience. Pro Neurobiol. 87:133–170.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Subr V. 2004. Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev. 56:1023–1050.
   PubMed Web of Science ®Google Scholar
• Whitters CJ, Strang R, Brown D, Clarke RL, Curtis RV, Hatton PV, et al. 1999. Dental materials: 1997 literature review. J Dent. 27: 401–435.
   PubMed Web of Science ®Google Scholar
• Wu C, Zreiqat H. 2010. Porous bioactive diopside (CaMgSi2O6) ceramic microspheres for drug deliver. Acta Biomater. 6:820–829.
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 6:1794–1807.
   PubMed Web of Science ®Google Scholar
• Wu X, Wu M, Zhao JX. 2014. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. Nanomedicine. 10:297–312.
   PubMed Web of Science ®Google Scholar
• Yacobi NR, Phuleria HC, Demaio L, Liang CH, Peng CA, Sioutas C, et al. 2007. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro. 21:1373–1381.
   PubMed Web of Science ®Google Scholar
• Zhang L. 2004. Preparation of multi-component ceramic nanoparticles. CISM. 8–21.
   Google Scholar
• Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. 2012. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Delivery Rev. 64:1364–1384.
   Google Scholar
• Zhou X, Porter LA, Robinson KRD, Shim SM, Guo Y. 2014. Nano-enabled drug delivery: a research profile. Nanomedicine. 10: 889–896.
   PubMed Web of Science ®Google Scholar
• Zou XD, Conradsson T, Klingstedt M, Dadachov MS, O’ Keeffe M. 2005. Mesostuctured germanium oxide with crystalline pore walls and its chiral derivative. Nature. 437:716–719.
   PubMed Web of Science ®Google Scholar